Trials / Conditions / Low Risk Myelodysplastic Syndromes
Low Risk Myelodysplastic Syndromes
4 registered clinical trials studyying Low Risk Myelodysplastic Syndromes — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS) NCT06670222 | Groupe Francophone des Myelodysplasies | Phase 1 |
| Recruiting | Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Ris NCT06614595 | Fundación para la Investigación Biosanitaria del Principado de Asturias | — |
| Active Not Recruiting | RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms NCT06243458 | GCP-Service International West GmbH | Phase 2 |
| Recruiting | Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) NCT05308264 | Rigel Pharmaceuticals | Phase 1 / Phase 2 |